相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deletion of Alzheimer's disease-associated CD33 results in an inflammatory human microglia phenotype
Jannis Wissfeld et al.
GLIA (2021)
The CD33 short isoform is a gain-of-function variant that enhances Aβ1-42 phagocytosis in microglia
Abhishek Bhattacherjee et al.
MOLECULAR NEURODEGENERATION (2021)
Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of TREM2 in Alzheimer's Disease by Splicing-Based Aggregation
Seonggyun Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain
Kostantin Kiianitsa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
Douglas P. Wightman et al.
NATURE GENETICS (2021)
Microglial? signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome
Katharina Cosker et al.
SCIENTIFIC REPORTS (2021)
A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia
Thomas M. Piers et al.
FASEB JOURNAL (2020)
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
Michael Ewers et al.
EMBO Molecular Medicine (2020)
Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration
Maud Gratuze et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease
Amanda McQuade et al.
NATURE COMMUNICATIONS (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model
Li Zhong et al.
NATURE COMMUNICATIONS (2019)
Evaluation of CD33 as a genetic risk factor for Alzheimer's disease
Steven Estus et al.
ACTA NEUROPATHOLOGICA (2019)
TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
Jorge L. Del-Aguila et al.
MOLECULAR NEURODEGENERATION (2019)
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Ana Griciuc et al.
NEURON (2019)
Neurodegenerative Disease-Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain
Hunter B. Dean et al.
FRONTIERS IN NEUROLOGY (2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk
Iris E. Jansen et al.
NATURE GENETICS (2019)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation
Motoaki Yanaizu et al.
SCIENTIFIC REPORTS (2018)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
Kai Schlepckow et al.
EMBO MOLECULAR MEDICINE (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Alzheimer's Disease Risk Genes and Mechanisms of Disease Pathogenesis
Celeste M. Karch et al.
BIOLOGICAL PSYCHIATRY (2015)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response
Li Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Yuka Atagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
Taylor R. Jay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis
Inge R. Holtman et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
FBN1 isoform expression varies in a tissue and development-specific fashion
Mary E. Burchett et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family
Y. Numasawa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
TREM2-and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
Qisheng Peng et al.
SCIENCE SIGNALING (2010)
Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease
Fanggeng Zou et al.
HUMAN MOLECULAR GENETICS (2008)
Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: Continuous shuttling to and from the plasma membrane regulated by cell stimulation
I. Prada et al.
NEUROSCIENCE (2006)
Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia
G Sessa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype
J Paloneva et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
分享论文
